Cite Filings / ADAPY / 0001104659-23-076368

Feed Companies Filings Check

Sign in

S-8 POS

Post-effective Amendment

Adaptimmune Therapeutics PLC Filed 2023-06-29 Acc 0001104659-23-076368

Documents 1

S-8 POS Post-effective Amendment , tm2320023d2_s8pos.htm

Around this filing

2025-10-28 S-8 POS Post-effective Amendment
2023-07-03 4 Options or other derivatives
2023-07-03 4 Options or other derivatives
2023-06-29 S-8 POS Post-effective Amendment
2023-06-29 S-8 POS Post-effective Amendment
2023-06-29 8-K Executive or director change
2023-06-27 4 Chief Executive Officer sold 2,333 shares at $0.92 ($2,146)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2320023d2_s8pos.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…